La cadena de opciones muestra datos clave de las opciones de acciones de Brookfield Office Props a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Brookfield Office Props..

Brookfield Office Props (OTC:BRKFF) Bolsa, Cadena de Opciones

Brookfield Office Properties Inc is a real estate investment firm. It acts as owner, operator, and developer of office and multifamily assets. The office property division defines the skylines of dynamic cities around the world, including gateway cities such as New York, London, Berlin, Toronto, and Sydney and the multifamily business owns, develops, renovates and manages approximately 40,000 high-quality rental apartment buildings in supply constrained markets of major cities such as New York and London, as well as high growth markets in the suburban U.S. In addition, it caters to tenants in financial services, government, and energy and resource sectors.

BROOKFIELD OFFCE PREF AAA by Brookfield Office Properties Inc.

Brookfield Office Properties Inc

News

ECARX Unveils EXP01 RISC-V Processor At Summit In Paris, Advances Next-Gen MCU Roadmap And Deepens Ecosystem Ties For Smart Mobility

Needham analyst Joshua Reilly reiterates Twilio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) with a Buy and maintains $125 price target.

Price Target

Reiteration

Analyst Ratings

TWLO

Needham Reiterates Buy on Twilio, Maintains $125 Price Target

ATA Creativity Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) raises FY2025 sales outlook from $37.81 million-$38.50 million to $38.03 million-$38.72 million.

Guidance

AACG

ATA Creativity Global Raises FY2025 Sales Guidance from $37.81M-$38.50M to $38.03M-$38.72M

Barclays analyst Adrienne Yih downgrades Foot Locker (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FL#NYSE">FL</a>) from Overweight to Equal-Weight and raises the price target from $14 to $24.

Downgrades

Barclays Downgrades Foot Locker to Equal-Weight, Raises Price Target to $24

NGNE

Neurogene Announces Evidence-Based Monitoring And Treatment Intended To Reverse Rare Hyperinflammatory Syndrome Associated with High-Dose AAV

ATA Creativity Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AACG#NASDAQ">AACG</a>) reported quarterly losses of $(0.06) per share. This is a 25 percent increase over losses of $(0.08) per share from the same period last year. The company reported $7.69 million in sales this quarter. This is a 15.35 percent increase over sales of $6.67 million the same period last year.

Earnings

ATA Creativity Glb Q1 Adj. EPS $(0.06) Up From $(0.08) YoY, Sales $7.69M Up From $6.67M YoY

Management

Novo Nordisk CEO Lars Fruergaard Jørgensen To Step Down, Search For Successor Is Ongoing; Lars Fruergaard Jørgensen Will Continue As CEO For A Period Amid Transition

HC Wainwright &amp; Co. analyst Matthew Caufield reiterates Zenas BioPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZBIO#NASDAQ">ZBIO</a>) with a Buy and maintains $30 price target.

ZBIO

HC Wainwright & Co. Reiterates Buy on Zenas BioPharma, Maintains $30 Price Target

<a href="https://www.globenewswire.com/Tracker?data=BkCKt-Jh3o9pFkwpuXgGU5ejQK8a8a-6BBr8QPEWbezjCS3HSbIn6MZu2BrF3K4-6CNVWvAz87mz5l-J-QHkTCGuDJhNwh27kKWJUW2V__orBgkeKeVWnIdL6QKzKArS">BioCryst Pharmaceuticals, Inc.</a> (Nasdaq:&nbsp;BCRX) today announced new real-world evidence on the use of oral, once-daily ORLADEYO&#xAE; (berotralstat) in adolescents and people with severe HAE showing significant and sustained reductions in HAE attack rates through 18 months of follow-up after beginning treatment with ORLADEYO in both patient populations.
The real-world evidence was presented in two posters at the 2025 International Society for Pharmacoeconomics and Outcomes Research conference (ISPOR), which is being held in Montreal from May 13-16, 2025.

BCRX

BioCryst Pharma Presents New Real-World Evidence Showing ORLADEYO Delivers Sustained HAE Attack Reduction in Adolescents & Severe Cases

As ValueAct Holdings, LP. buys a fresh stake in Rocket Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>), Andrew Left&#8216;s Citron Research endorses the move, calling the investment a &#8220;multi-year story.&#8221;
What Happened: The co-CEO and CIO of ValueAct, Mason Morfit, added 6.728 million shares worth $81.213 million to its portfolio during the first quarter, according to its 13F filings.
The company represented 1.8% of ValueAct&#8217;s total holdings as of the first quarter.
However, Rocket&#8217;s recent SEC filing dated May 15 showed that ValueAct held 15.125 million shares in the company, representing 9.9% of the total stake.
Citron Research cited this in an X post and lauded the co-CEO, Morfit, for being the &#8220;most strategic, long-term thinkers&#8221; and stating that he is one of the minds who reshaped Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) from the boardroom. 
&#8220;When someone like that sees $RKT as a compounder, it's not about quarterly noise—it's the start of a multi-year story,&#8221; said Citron&#8217;s post.
Highlighting Morfit&#8217;s comments, it added, &#8220;The CEO called Rocket a &#8216;sleeping giant&#8217; in its &#8216;early innings&#8217; yesterday,&#8221; the post added.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24RKT&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$RKT</a> – Game on. ValueAct just filed a 10% stake. Mason Morfit isn't just any investor—he's the mind who reshaped Microsoft from the boardroom. Citron has been active on Wall Street for 25+ years, and Morfit remains one of the most strategic, long-term thinkers we've ever met.…
&mdash; Citron Research (@CitronResearch) <a href="https://twitter.com/CitronResearch/status/1923119403777786252?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/general/market-summary/25/05/45399940/warren-buffett-shows-how-patience-pays-98-of-his-160-billion-wealth-came-after-turning-65-thanks-the-power-of-compound-interest">Warren Buffett Shows How Patience Pays: 98% Of His $160 Billion Wealth Came After Turning 65, Thanks The Power Of &#8216;Compound Interest&#8217;</a>
Why It Matters: Apart from Rocket Companies, ValueAct&#8217;s 13F filings showed 13 more companies that the firm held a stake in, after the first quarter. Here is a list of all its holdings.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Holdings As Of Q1</td>
<td>Stake</td>
<td>Value (In Million)</td>
</tr>
<tr>
<td>Salesforce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>)</td>
<td>17%</td>
<td>$777.84</td>
</tr>
<tr>
<td>Walt Disney Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>)</td>
<td>14%</td>
<td>$648.07</td>
</tr>
<tr>
<td>Insight Enterprises Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NASDAQ">NSIT</a>)</td>
<td>13%</td>
<td>$609.22</td>
</tr>
<tr>
<td>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</td>
<td>13%</td>
<td>$584.93</td>
</tr>
<tr>
<td>Roblox Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>)</td>
<td>11%</td>
<td>$510.91</td>
</tr>
<tr>
<td>Visa Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/V#NYSE">V</a>)</td>
<td>10%</td>
<td>$460.14</td>
</tr>
<tr>
<td>Liberty Media Corp. Series C (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LLYVK#NASDAQ">LLYVK</a>)</td>
<td>5.80%</td>
<td>$266.01</td>
</tr>
<tr>
<td>Expedia Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXPE#NASDAQ">EXPE</a>)</td>
<td>4.10%</td>
<td>$187.79</td>
</tr>
<tr>
<td>Live Nation Entertainment Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LYV#NYSE">LYV</a>)</td>
<td>2.50%</td>
<td>$115.60</td>
</tr>
<tr>
<td>Liberty Media Corp. Series A (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LLYVA#NASDAQ">LLYVA</a>)</td>
<td>2.40%</td>
<td>$111.53</td>
</tr>
<tr>
<td>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</td>
<td>2.30%</td>
<td>$107.14</td>
</tr>
<tr>
<td>Toast Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOST#NYSE">TOST</a>)</td>
<td>1.90%</td>
<td>$86.15</td>
</tr>
<tr>
<td>Rocket Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RKT#NYSE">RKT</a>)</td>
<td>1.80%</td>
<td>$81.21</td>
</tr>
<tr>
<td>Nu Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>)</td>
<td>0.80%</td>
<td>$34.98</td>
</tr>
</tbody>
</table>
</figure>
Price Action: Shares of RKT rose 1.35% on Thursday. The stock was up 17.70% on a year-to-date basis, but 8% lower over a year. It was trading nearly 6% higher during the premarket session on Friday.
Benzinga Edge Stock Rankings shows that RKT had a stronger price trend over the short and the medium term but a weaker trend over the long term. Its momentum ranking was moderate at the 37.21th percentile. You can check the details of other metrics <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">over here</a>. 
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound"><img loading="lazy" decoding="async" width="1024" height="147" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16064327/RKT-EDGE-1024x147.png" alt="" class="wp-image-917733" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16064327/RKT-EDGE-1024x147.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16064327/RKT-EDGE-300x43.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16064327/RKT-EDGE-768x110.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16064327/RKT-EDGE.png 1219w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, were higher in premarket on Friday. The SPY was up 0.24% to $591.85, while the QQQ advanced 0.24% to $520.50, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/market-summary/25/05/45461488/walmart-e-commerce-turns-profitable-for-the-first-time-despite-reduced-tariffs-ceo-says-full-impact-cant-be-absorbed-price-hikes-likely">Walmart E-Commerce Turns Profitable For The First Time: Despite Reduced Tariffs, CEO Says Full Impact Can&#8217;t Be Absorbed, Price Hikes Likely</a></li>
</ul>
Image Via Shutterstock

Equities

Market Summary

Broad U.S. Equity ETFs

Futures

Hedge Funds

Markets

ETFs

General

AMZN

EXPE

LLYVA

LLYVK

MSFT

NSIT

RBLX

TOST

Rocket Companies Soars 6% In Friday Premarket As Activist Investor ValueAct Reveals New Position, Calls RKT A 'Sleeping Giant' In Early Innings

Longbow Research analyst David Macgregor initiates coverage on HNI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HNI#NYSE">HNI</a>) with a Buy rating and announces Price Target of $70.

Initiation

Longbow Research Initiates Coverage On HNI with Buy Rating, Announces Price Target of $70

Flowers Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLO#NYSE">FLO</a>) lowers FY2025 Adj EPS guidance from $1.18-$1.28 to $1.05-$1.15 vs $1.16 analyst estimate. Lowers FY2025 sales outlook from $5.18 billion-$5.26 billion to $5.08 billion-$5.17 billion vs $5.41 billion estimate.

FLowers Foods Lowers FY2025 Adj EPS Guidance from $1.18-$1.28 to $1.05-$1.15 vs $1.16 Est; Lowers FY2025 Sales, Excluding the Simple Mills acquisition Guidance from $5.18B-$5.26B to $5.08B-$5.17B vs $5.41B Est

WIIM

ORGN

Origin Materials shares are trading lower after the company reported a year-over-year decrease in Q1 financial results and cut its FY26 sales guidance below estimates.

GLOB

Globant shares are trading lower after the company reported worse-than-expected Q1 financial results, issued Q2 guidance below estimates, and cut its FY25 guidance.

LGCY

Legacy Education shares are trading higher after the company reported better-than-expected Q3 financial results.

Tawazun, RTX, And EGA Partner To Establish UAE As World's Second-Largest Gallium Producer, Boosting Global Tech And Defense Supply Chains

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
<h3 class="wp-block-heading">Altria Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 7.03%</li>
<li>Barclays analyst Gaurav Jain maintained an Underweight rating and raised the price target from $46 to $49 on May 2, 2025. This analyst has an accuracy rate of 65%.</li>
<li>B of A Securities analyst Lisa Lewandowski upgraded the stock from Neutral to Buy and raised the price target from $55 to $65 on Dec. 6, 2024. This analyst has an accuracy rate of 64%.</li>
<li>Recent News: On April 29, Altria Group posted upbeat quarterly earnings.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to latest MO <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516">news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516"><img loading="lazy" decoding="async" width="913" height="847" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065718/image-196.png" alt="" class="wp-image-917747" style="width:637px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065718/image-196.png 913w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065718/image-196-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065718/image-196-768x712.png 768w" sizes="(max-width: 913px) 100vw, 913px" /></a></figure>
<h3 class="wp-block-heading">Conagra Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CAG#NYSE">CAG</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 6.15%</li>
<li>JP Morgan analyst Ken Goldman maintained a Neutral rating and cut the price target from $26 to $25 on May 6, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Morgan Stanley analyst Megan Alexander initiated coverage on the stock with an Equal-Weight rating and a price target of $27 on March 24, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On May 1, Hometown Food Company announced plans to acquire Chef Boyardee Brand from Conagra Brands for $600 million.</li>
<li>Benzinga Pro's real-time newsfeed alerted to latest CAG <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516">news </a></li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516"><img loading="lazy" decoding="async" width="848" height="792" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065756/image-197.png" alt="" class="wp-image-917749" style="width:606px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065756/image-197.png 848w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065756/image-197-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065756/image-197-768x717.png 768w" sizes="(max-width: 848px) 100vw, 848px" /></a></figure>
<h3 class="wp-block-heading">General Mills, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GIS#NYSE">GIS</a>)</h3>
<ul class="wp-block-list">
<li>Dividend Yield: 4.41%</li>
<li>Morgan Stanley analyst Megan Alexander initiated coverage on the stock with an Underweight rating and a price target of $53 on March 24, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Mizuho analyst John Baumgartner maintained a Neutral rating and cut the price target from $62 to $60 on March 20, 2025. This analyst has an accuracy rate of 67%.</li>
<li>Recent News: On March 19, General Mills reported mixed third-quarter results and said it expects macroeconomic uncertainty to continue impacting consumers in the fourth quarter.</li>
<li>Benzinga Pro&#8217;s real-time newsfeed alerted to <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516">latest GIS news</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0516"><img loading="lazy" decoding="async" width="916" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065837/image-198.png" alt="" class="wp-image-917750" style="width:574px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065837/image-198.png 916w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065837/image-198-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/16065837/image-198-768x693.png 768w" sizes="(max-width: 916px) 100vw, 916px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45462276/applied-materials-flowers-foods-and-3-stocks-to-watch-heading-into-friday">Applied Materials, Flowers Foods And 3 Stocks To Watch Heading Into Friday</a> </li>
</ul>
Photo via Shutterstock

Dividends

Pre-Market Outlook

Trading Ideas

Wall Street's Most Accurate Analysts Give Their Take On 3 Defensive Stocks Delivering High-Dividend Yields

TSSI

TSS shares are trading higher after the company reported a year-over-year increase in Q1 revenue results.

Flowers Foods (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLO#NYSE">FLO</a>) is looking for FY2025 GAAP EPS of $0.95-$1.05 vs $1.16 analyst estimate. Lowers FY2025 sales outlook from $5.40 billion-$5.49 billion to $5.30 billion-$5.39 billion vs $5.41 billion estimate.

FLowers Foods Sees FY2025 GAAP EPS $0.95-$1.05 vs $1.16 Est; Lowers FY2025 Sales Guidance from $5.40B-$5.49B to $5.30B-$5.39B vs $5.41B Est

DOCS

Doximity shares are trading lower after the company issued FY26 and Q1 sales guidance below estimates.

Brookfield Office Props

Comments

Brookfield Office Props

Brookfield Office Props (BRKFF) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL